The analysis reviews Palantir's stock, currently at $153.92, noting a recent 20% drop from all-time highs. Citron Research has issued a report indicating Palantir stock is overvalued, citing its price-to-sales multiple being nearly seven times that of OpenAI. The analysis suggests that Palantir’s forward price-to-earnings ratio was at approximately 250 before the drawdown. While acknowledging Palantir’s strong performance and improved free cash flow (forecast to increase from $1.93 billion in 2025 to $35 billion by 2035), the presenter states that the current valuation is still overdone. The intrinsic value per share, as per their discounted cash flow valuation, is $44.89. The analysis advocates a "hold" rating on the stock and the actual rating is "Hold/Market Perform" based on 08/20/2025.